The FDA is considering utilizing large language models to improve efficiency in its oversight responsibilities, notably in the drug approval process. In their publication in JAMA, FDA officials proposed using AI to accelerate reviews of extensive drug applications and medical devices. They also aim to quickly approve healthier food options for children. However, experts have expressed skepticism, questioning the agency’s capacity to maintain independence from pharmaceutical influence while emphasizing a caution against a cozy relationship with the industry.
The FDA aims to leverage AI, including large language models, to enhance efficiency in drug application reviews and expedite the approval process for pharmaceuticals and food.
Experts express concerns that the FDA's prioritization of AI for reviews appears aligned with the interests of the pharmaceutical industry, raising doubts about agency independence.
Collection
[
|
...
]